Clinical Trial Update: The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps [Phase 2]

View source ↗

Summary

This document reports that the Phase 2 study of GR1802 for chronic rhinosinusitis with nasal polyps is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• GR1802 (GR1802)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Chronic Rhinosinusitis with Nasal Polyps | Phase 2 | Status: ACTIVE_NOT_RECRUITING